Myriad Genetics (MYGN)

Add to Watchlists Create an Alert
37.05 +0.94  +2.60% NASDAQ Jul 29, 8:00PM BATS Real time Currency in USD
View Full Chart
MYGN Price Chart
View All Events

MYGN Events

Date Type Description
05/06/2014 16:30 EDT Misc Q3 2014 Myriad Genetics Inc Earnings Conference Call
05/06/2014 Earnings Q3 2014 Myriad Genetics Inc Earnings Results. Estimate: 0.46.
02/04/2014 16:30 EDT Misc Myriad Genetics, Inc. 2Q2014 Earning Conference Call
02/04/2014 Earnings Myriad Genetics, Inc. 2Q2014 Earning Result. Estimate: 0.47.
12/12/2013 19:30 CST Misc Myriad Genetics Announces Upcoming Investor Event
12/05/2013 Misc AGM Event for Myriad Genetics, Inc.
11/05/2013 16:30 EDT Misc Myriad Genetics to Announce Fiscal First Quarter 2014 Financial Results Conference Call
11/05/2013 Earnings Myriad Genetics to Announce Fiscal First Quarter 2014 Financial Results on Tuesday November 5, 2013. Estimate: 0.46.
08/13/2013 16:30 EDT Misc Myriad Genetics Announces Date of Full-year and Fourth-quarter Fiscal 2013 Financial Results Conference Call
08/13/2013 Earnings Myriad Genetics Announces Fourth-Quarter Fiscal 2013 Financial Results. Estimate: 0.43.
View All Performance Charts

MYGN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Myriad Genetics is up 17.89% over the last year vs S&P 500 Total Return up 18.90%, Affymetrix up 124.8%, and Laboratory of America up 7.16%.

Get Quote for

PDF Report for MYGN

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download MYGN Pro Report PDF

Portfolio Strategies Featuring MYGN

Did Myriad Genetics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

MYGN Profile

  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Company Website:
  • IR Website:
  • HQ Country: United States
  • HQ State/Province: Utah
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: June 30, 2015
  • Last Fiscal Quarter End: March 31, 2014
  • Last Fiscal Year End: June 30, 2013
  • NAICS: In-Vitro Diagnostic Substance Manufacturing
  • NAICS Code: 325413
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Myriad Genetics Inc is engaged in the discovery and commercialization of transformative tests which assess a persons risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence.

MYGN Excel Add-In Codes

  • Name: =YCI("MYGN","name")
  • Description: =YCI("MYGN","description")
  • Sector: =YCI("MYGN","sector")
  • Industry: =YCI("MYGN","industry")
  • Est. Current Fiscal Year End: =YCI("MYGN","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start your {{}} Membership


{{ ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{}} Member? Sign in here.